Bipartisan group of lawmakers opposes Biden’s plan to use ‘march-in’ to lower drug prices

A group of 28 senators and members of Congress, including nine Democrats, sent a letter to President Joe Biden on Wednesday decrying his administration’s recent proposal to exercise its so-called march-in rights when drug prices rise too high.

Biden’s plan, unveiled in December in guidance from the…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks